Biological Sciences Tech Calls | Innoget

Find Tech Calls in Biological Sciences, Neurology, Nanotechnology, Biochemistry, Microbiology, Bionics, Ehealth and more posted by leading companies on Innoget

  1. Home
  2. Technology Calls
  3. Biological Sciences
Open Science has turned to be one of the key resources for Industry and financial development. Thanks to Open Innovation platforms and Open Innovation communities, collaboration in research and development between businesses and outer groups of specialists, for instance, Universities, research organizations, startups and scientists is thriving innovation and new product development in the sectors of molecular biology, ehealth, biological sciences, genome research, gene expression, bioplastics, biophysics and bacteriology, among many other areas of research. Innoget, the largest open innovation community for technology and knowledge transfer, offers a unique way to directly interact with large enterprises, SMEs and other industry players who are looking for novel technologies. Find below the full list of Technology Calls related to Biological Sciences.

Ani Oganesyan posted this Technology Call
International projects lead at GenerationS Corporate Accelerator Based on RVC

We are looking for biodegradable coatings for controlled release fertilizers on behalf of the biggest world fertilizer producer. In case of a perfect match, the technology may receive solid investments or get value from other forms of collaboration.
Seeking for biodegradable coatings for controlled release fertilizers

Covid-19 Innovation Challenges by Innoget posted this Technology Call

Nurses have always been critical partners on the frontlines of care, and the backbone of our healthcare system. The COVID-19 pandemic has raised new challenges for nurses and health workers and brought into focus the obstacles that they face around the world, every day. The power of nurse-led innovation and know-how may be more critical than ever when developing potential solutions amid a global crisis. With extensive patient experience, nurses’ ideas have the potential to profoundly improve human health. In connection with our overall commitment to supporting frontline healthcare workers amid the COVID-19 pandemic, Johnson & Johnson is proud to continue the Nurses Innovate QuickFire Challenges series with a new challenge inspired by the NurseHack4Health: COVID-19 Virtual Hackathon where over 500 nurses, healthcare professionals, and tech enthusiasts convened virtually to help ideate potential solutions for COVID-19 health challenges. This QuickFire Challenge is open to all nurse innovators, and aims to help nurture early-stage ideas from the frontlines of COVID-19 by celebrating, supporting, & mentoring the nurse innovators behind them. Introducing the Johnson & Johnson Nurses Innovate QuickFire Challenge in COVID-19 Patient Care together with the American Organization for Nursing LeadershipTM (AONL) and the Society of Nurse Scientists, Innovators, Entrepreneurs, & Leaders (SONSIEL). Nurses from around the world are invited to submit ideas aiming to improve COVID-19 patient care. The nurse innovators with the best idea(s) will receive up to $100,000 in grant funding, mentoring from experts across the Johnson & Johnson Family of Companies, and access to the Johnson & Johnson Innovation – JLABS ecosystem to help bring their ideas to life. As innovators on the frontlines of healthcare, nurses have the power to profoundly change lives. Johnson & Johnson has the scale, resources and know-how to help move them forward. Put these two together, and that changes everything. We have never stopped and never will stop advocating for, elevating and empowering nurses as innovative, critical leaders on the frontline. Learn more about nurses who innovate, and the commitment Johnson & Johnson has made to nurses over the past 120 years at https://nursing.jnj.com/our-commitment. Learn more about how we are supporting front line health workers amid the COVID-19 Pandemic
Seeking nurse-led ideas from nurses and nursing students around the world focused on improving COVID-19 patient care

PepsiCo posted this Technology Call

We have been working on bio-based/biodegradable flexible films for food packaging to help achieve our sustainability goals of having 100% RCB compliance for our packages as well as 20% reduction in GHG by 2030. While flexible package is a very sustainable option from a material use point of view, the multi-layer multi-material structures are not conducive for recycling and mostly end up in the landfill or as litter. While the biodegradable films help us with the end of life issues by designing for managed waste infrastructures like composting and anaerobic digestion, it cannot be at the expense of performance compromises such as reduced shelf stability. Oxygen barrier is not a problem with these films but achieving the very high moisture barrier required for packaging dry foods (< 0.3 g/m2/day under tropical conditions of 38C/90% RH) has been a challenge. We understand that metallization will be needed to achieve the high moisture barrier requirements, but even with metallization we have not been able to reach this barrier with bio-based films. Also, it is important to maintain this barrier under forming conditions in the VFFS process of bag-making. We are looking for novel resins that can be co-extruded with our core resins to form a skin layer with high functionality that can anchor metal to film or highly functional coatings which would serve the same purpose. Inherently high barrier coatings that can be applied as primer coating or top coating over metal could also be a solution.
Seeking moisture barrier for bio-based films

Covid-19 Innovation Challenges by Innoget posted this Technology Call

While the implications of the pandemic are still unfolding, countries across the world are preparing for life in the “New Normal.” In this period of transition, forward-thinking innovations aiming to address healthcare challenges are needed more than ever. Through disruption, we must leverage data and health technologies to accelerate potentially life-saving ideas aiming to improve patient care through the uncharted times that lay ahead. That is why Johnson & Johnson Innovation—JLABS (“JLABS”), in collaboration with Seoul Metropolitan Government (“SMG”), Korea Health Industry Development Institute (“KHIDI”), Janssen Korea Ltd., is launching the Seoul Innovation QuickFire Challenge for Healthcare in the New Normal. Up to two innovators with the best ideas aiming to address and enable potential healthcare solutions in the post-COVID era will receive up to KRW150,000,000 (approximately US$125,000[1]) in grant funding, residency at the Seoul Bio Hub, and mentorship and coaching from experts at the Johnson & Johnson Family of Companies. [1] From the KRW150 million grant, each awardee will receive a KRW75 million grant including one-year mandatory residency, which must be used toward the rent and utilities at the Seoul Bio Hub for a year. Estimate based on exchange rate of 0.00083 in June 2020
Seeking novel proposals aiming to address and enable healthcare solutions in the post-COVID era